Trials / Sponsors / Editas Medicine, Inc.
Editas Medicine, Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Wh Sickle Cell Disease, Transfusion-dependent Beta-Thalassemia, Hemoglobinopathies | — | 2024-06-17 |
| Active Not Recruiting | EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent B Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major | Phase 1 / Phase 2 | 2022-04-29 |
| Active Not Recruiting | A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) Sickle Cell Disease, Hemoglobinopathies | Phase 1 / Phase 2 | 2021-05-04 |
| Unknown | Single Ascending Dose Study in Participants With LCA10 Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary | Phase 1 / Phase 2 | 2019-09-26 |
| Completed | Natural History Study of CEP290-Related Retinal Degeneration Blindness, Leber Congenital Amaurosis 10, Vision Disorders | — | 2017-12-17 |